← Open Payments lookup

MICHAEL LOWNEY: Open Payments

NPI 1205063930 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,822 in 84 payments from 18 companies in 2025. Trend: 2023 $2,150 · 2024 $1,686 · 2025 $1,822

Food & beverage: $1,822
CompanyPaymentsAmount
Lilly USA, LLC14$278
AstraZeneca Pharmaceuticals LP11$241
PFIZER INC.11$226
Boehringer Ingelheim Pharmaceuticals, Inc.9$203
Novo Nordisk Inc6$164
ABBVIE INC.10$142
Astellas Pharma US Inc4$119
Otsuka America Pharmaceutical, Inc.4$99
Lundbeck LLC3$95
E.R. Squibb & Sons, L.L.C.2$46

Products named: JARDIANCE, FARXIGA, REXULTI, Veozah, VRAYLAR, NURTEC ODT, Wegovy, ELIQUIS.

Industry payments across MA — which companies pay providers there.